Chiome Bioscience Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 56
Employees
  • Stock Symbol
  • 4583
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $2.09
  • (As of Monday Closing)

Chiome Bioscience General Information

Description

Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
TKS
Primary Office
  • Tokyo Honcho Third Street No. 12
  • Number 1 Sumitomo Fudosan Nishi building Building No. 6, Shibuya-ku
  • Tokyo, 151-0071
  • Japan
+81 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chiome Bioscience Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.09 $2.17 $1.70 - $3.49 $84.4M 40.3M 1.53M -$0.23

Chiome Bioscience Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 76,285 45,477 38,871 19,305
Revenue 6,502 4,503 4,105 1,927
EBITDA (8,900) (12,042) (12,810) (13,800)
Net Income (9,074) (12,116) (12,876) (13,885)
Total Assets 30,112 33,884 25,787 25,656
Total Debt 1,719 1,745 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Chiome Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chiome Bioscience‘s full profile, request access.

Request a free trial

Chiome Bioscience Executive Team (5)

Name Title Board Seat Contact Info
Masa Fujiwara Chief Executive Officer & President
Shigeru Kobayashi Representative Director & President
Tsutomu Kawaguchi Ph.D Executive Director & Supervisory Board Member
Kunihiro Ohta Ph.D Executive Director
Keiichi Kiyota Executive Director & Chief Financial Officer
To view Chiome Bioscience’s complete executive team members history, request access »

Chiome Bioscience Board Members (10)

Name Representing Role Since
Akira Furuya Self Board Member 000 0000
Haruhisa Kubota Self Board Member 000 0000
Nobuo Taguchi Chiome Bioscience Audit & Supervisory Board Member 000 0000
Tsutomu Kawaguchi Ph.D Chiome Bioscience Executive Director & Supervisory Board Member 000 0000
Yasuhiro Tsuji Ph.D Chiome Bioscience Audit & Supervisory Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Chiome Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chiome Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Chiome Bioscience‘s full profile, request access.

Request a free trial

Chiome Bioscience Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 01-Dec-2018 000000000000000000 00.000 Biotechnology
0000000 13-Mar-2015 000000000 00000000 Biotechnology
LivTech 25-Dec-2013 Merger/Acquisition 00000 Biotechnology
To view Chiome Bioscience’s complete investments and acquisitions history, request access »